Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term KeyWords Plus:. Found 82 abstracts

no pagination
Andrews SF, Anderson PR, Eisenberg BL, Hanlon AL, Pollack A. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy. International Journal of Radiation Oncology Biology Physics. 2004 Jun;59(2):475-80.
Arias-Mendoza F, Smith MR, Brown TR. Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. Academic radiology. 2004 Apr;11(4):368-76.
Barsevick AM, Dudley W, Beek S, Sweeney C, Whitmer K, Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004 Mar;100(6):1302-10.
Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A. Psychometric evaluation of the Pittsburgh sleep quality index in cancer patients. Journal of Pain and Symptom Management. 2004 Feb;27(2):140-8.
Blanchard RL, Freimuth RR, Buck J, Weinshilboum RM, Coughtrie MW. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics. 2004 Mar;14(3):199-211.
Bloom BS, de Pouvourville N, Chhatre S, Jayadevappa R, Weinberg D. Breast cancer treatment in clinical practice compared to best evidence and practice guidelines. British Journal of Cancer. 2004 Jan;90(1):26-30.
Bruner DW, Hanlon A, Mazzoni S, Raysor S, Konski A, Hanks G, Pollack A. Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer. International Journal of Radiation Oncology Biology Physics. 2004 Jan;58(1):34-42.
Bruner DW, Movsas B, Konski A, Roach M, Bondy M, Scarintino C, Scott C, Curran W. Outcomes research in cancer clinical trial cooperative groups: The RTOG model. Quality of Life Research. 2004 Aug;13(6):1025-41.
Chen JQ, Delannoy M, Cooke C, Yager JD. Mitochondrial localization of ER alpha and ER beta in human MCF7 cells. American Journal of Physiology-Endocrinology and Metabolism. 2004 Jun;286(6):E1011-E1022.
Chen ZJ, Vulevic B, Ile KE, Soulika A, Davis W, Reiner PB, Connop BP, Nathwan P, Trojanowski JQ, Tew KD. Association of ABCA2 expression with determinants of Alzheimer's disease. Faseb Journal. 2004 May;18(7):U606-U626.
Chism DB, Hanlon AL, Horwitz EM, Feigenberg SJ, Pollack A. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy. International Journal of Radiation Oncology Biology Physics. 2004 Jun;59(2):380-5.
Cohen SJ, Gallo J, Lewis NL, Alpaugh RK, Gentner L, Rogatko A, Yeslow G, Schol J, Verhaeghe T, Zannikos P, Palmer PA, Weiner LM, Meropol NJ. Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 2004 Jun;53(6):513-8.
Comunale MA, Mattu TS, Lowman MA, Evans AA, London WT, Semmes OJ, Ward M, Drake R, Romano PR, Steel LF, Block TM, Mehta A. Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. Proteomics. 2004 Mar;4(3):826-38.
Dimitrova I, Toby GG, Tili E, Strich R, Kampranis SC, Makrisa AM. Expression of Bax in yeast affects not only the mitochondria but also vacuolar integrity and intracellular protein traffic. Febs Letters. 2004 May;566(1-3):100-4.
Dreicer R, Manola J, Roth BJ, See WA, Kuross S, Edelman MJ, Hudes GR, Wilding G. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium - A trial of the eastern cooperative oncology group. Cancer. 2004 Apr;100(8):1639-45.
Guo SC, Russo IH, Lareef MH, Russo J. Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. International Journal of Oncology. 2004 Feb;24(2):399-407.
Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A. The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer. Cancer. 2004 Feb;100(3):538-43.
Konski A, Watkins-Bruner D. The RTOG Outcomes Model: economic end points and measures. Expert Opinion on Pharmacotherapy. 2004 Mar;5(3):513-9.
Lareef MH, Tahin Q, Song J, Russo IH, Mihaila D, Slater CM, Balsara B, Testa JR, Broccoli D, Grobelny JV, Mor G, Cuthbert A, Russo J. Chromosome 17p13.2 transfer reverts transformation phenotypes and Fas-mediated apoptosis in breast epithelial cells. Molecular Carcinogenesis. 2004 Apr;39(4):234-46.
Li JS, Freedman GM, Price R, Wang L, Anderson P, Chen L, Xiong W, Yang J, Pollack A, Ma CM. Clinical implementation of intensity-modulated tangential beam irradiation for breast cancer. Medical Physics. 2004 May;31(5):1023-31.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term KeyWords Plus:

KeyWords Plus: quality of life THERAPY RADICAL PROSTATECTOMY RADIOTHERAPY QUALITY-OF-LIFE RADIATION-THERAPY IRRADIATION SURVIVAL radiation therapy economic analysis OUTCOMES prostate cancer ADJUSTED SURVIVAL ANALYSIS breast cancer radiotherapy CELL LUNG-CANCER PROSTATE-CANCER CARCINOMA clinical trials ANTIGEN IN-VIVO BIOCHEMICAL FAILURE dose escalation PATIENT PREFERENCES glutathione S-transferase outcomes research farnesyltransferase inhibitor utility IMMOBILIZED PH GRADIENTS ADJUVANT BRACHYTHERAPY in vivo metabolism DOSING REGIMENS MCF-7 cells ESTROGEN-RECEPTOR-BETA COSTS RANDOMIZED PHASE-III PITUITARY-TUMOR CELLS PATIENTS RECEIVING CHEMOTHERAPY PSYCHOLOGICAL-ASPECTS PHOTON BEAMS COMPENSATORS COMBINATION RESECTION HIGH-DOSE CHEMOTHERAPY measurement IMRT fatigue CANCER CELLS yeast SULT DIFFERENTIAL REGULATION INDUCED APOPTOSIS BRAIN PACLITAXEL PLUS CARBOPLATIN SUPPRESSES FLUOROURACIL FAILURE BREAST-CANCER RESISTANCE HUMAN DOPAMINE SULFOTRANSFERASE TELOMERASE ACTIVITY chromosome 17p132 intensity modulation PLUS CISPLATIN INTACT BREAST treatment predictor ALLELE LOSS O-PHOSPHORYLATION ONCOLOGY GROUP RTOG OVEREXPRESSION phospholipid intermediates BEAM RADIATION-THERAPY prostate carcinoma IMPACT HUMAN BRAIN CHEMICAL-CARCINOGENS 12-DIMETHYLBENZANTHRACENE-INDUCED DNA-BINDING 7 apoptosis cytosolic sulfotransferases mitochondrial deoxyribonucleic acid-encoded genes programmed cell death cancer INDUCTION evidence-based medicine phase I CHEMOTHERAPY RECONSTRUCTION local control B-CELL LYMPHOMA MALIGNANT GLIOMA COMMUNITY ONCOLOGY DISCOVERY IN-SITU HYBRIDIZATION RANDOMIZED-TRIALS FATIGUE POOR-PROGNOSIS alleles CERULOPLASMIN RT-PCR DOSE CALCULATION TOOL insomnia DELIVERY symptom management transformation phenotypes PROTOCOL INDEPENDENT GROWTH TRANSPORTER GENE HEPATOCELLULAR-CARCINOMA RABBIT UTERUS MASS-SPECTROMETRY human breast epithelial cells mitochondria ADJUVANT CHEMOTHERAPY TUMOR-SUPPRESSOR GENES beta-amyloid sleep SACCHAROMYCES-CEREVISIAE PROTEINS RANDOMIZED-TRIAL OBSTRUCTIVE PULMONARY-DISEASE CLONING DECISION-ANALYSIS SHORT ARM STAGE-I MAGNETIC-RESONANCE SPECTROSCOPY 2-DIMENSIONAL GEL-ELECTROPHORESIS HEALTH STATES Bax ANTIGEN DENSITY PROGNOSTIC-SIGNIFICANCE nomenclature hepatocellular carcinoma COST-EFFECTIVENESS ANALYSIS symptom clusters mortality preferences CDNA CLONING BREAST-CANCER CELLS METASTATIC COLORECTAL-CANCER vacuole risk models R115777 ESTROGEN SULFOTRANSFERASE GLUCOCORTICOID-RESPONSIVE ELEMENTS MAMMARY EPITHELIAL-CELLS FARNESYL TRANSFERASE INHIBITOR resistance CONSERVING SURGERY PHYSICAL PERFORMANCE REGIMEN
Last updated on Sunday, July 05, 2020